Literature DB >> 10398447

All Patients with Recurrent Genital Herpes Should be Offered Suppressive Therapy with Acyclovir.

.   

Abstract

Entities:  

Year:  1996        PMID： 10398447     DOI： 10.1002/(SICI)1099-1654(199606)6:2<65::AID-RMV163>3.0.CO;2-S

Source DB:  PubMed          Journal:  Rev Med Virol        ISSN： 1052-9276            Impact factor:   6.989


× No keyword cloud information.
  2 in total

1.  Use of antiviral treatment and prophylaxis is unlikely to have a major impact on the prevalence of herpes simplex virus type 2.

Authors:  P J White; G P Garnett
Journal:  Sex Transm Infect       Date:  1999-02       Impact factor: 3.519

Review 2.  A risk-benefit evaluation of aciclovir for the treatment and prophylaxis of herpes simplex virus infections.

Authors:  S Leflore; P L Anderson; C V Fletcher
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.228
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.